Depressive disorder, major Trials in Marietta, United States
Conditions / Depressive disorder, major / Marietta, United States
Clinical trials for Depressive disorder, major investigate a range of treatment strategies and patient populations.
18 total trials for this combination
Showing top 10 of 18 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03668600 | Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD) | TERMINATED | PHASE3 |
| NCT02709746 | Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD) | COMPLETED | PHASE3 |
| NCT02951988 | A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT00316160 | Sexual Functioning Study With Antidepressants | COMPLETED | PHASE4 |
| NCT02709655 | Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD) | COMPLETED | PHASE3 |
| NCT01153009 | Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT04513912 | A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy | COMPLETED | PHASE3 |
| NCT00067444 | Depression Study In Elderly Patients | COMPLETED | PHASE3 |
| NCT05841030 | A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) | COMPLETED | — |
| NCT03002077 | Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |